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Abstract. The aim of this study was to determine the rate of undetected additional
anomalies following a prenatal diagnosis of isolated oral cleft. Data of all infants
with a prenatal diagnosis of isolated oral cleft born between 2000 and 2015 were
studied retrospectively. Additional anomalies detected after birth were categorized
as minor or major and included structural and chromosomal anomalies. Isolated
clefts of the lip (CL), lip and alveolus (CLA) and lip, alveolus, and palate (CLAP)
were diagnosed prenatally in 176 live-born infants. The type of cleft was more
extensive after birth in 34/176 (19.3%) and less extensive in 16/176 (9.1%)
newborns. Additional anomalies were diagnosed in 24 infants (13.6%), of which 12
(6.8%) were categorized as major. The latter included two submicroscopic
chromosome anomalies and two gene mutations. Postnatal additional anomalies
occurred more frequently in CLA and CLAP than in CL, and more in bilateral than
in unilateral clefts. Major anomalies are still found in infants with a prenatal
diagnosis of an isolated oral cleft. The prevalence of additional anomalies seems to
be related to the type and bilaterality of the cleft, and this should be considered
during prenatal counselling.Please cite this article in press as: Haj M, et al. Undetected anomalies in foetuses with a pre
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Accepted for publication 11 May 2020Oral cleft (OC) is the most common
congenital craniofacial anomaly, with an
incidence of 1:7001. The following phe-
notypes are distinguished: cleft lip (CL),
cleft lip and alveolus (CLA), cleft lip,
alveolus, and palate (CLAP), and cleft
palate (CP)1. The likelihood of the pres-
ence of other structural anomalies and
chromosomal anomalies increases when
an oral cleft is diagnosed2,3. The presence
of additional anomalies may result in achallenging start to life and may have a
substantial impact on the (psychosocial)
health of the child and parent4,5. Prenatal
assessment is important to determine the
type of OC and the presence of other
anomalies in order predict the outcome.
Counselling may enable parents to process
disappointment and prepare for adjusted
care during the pregnancy and after birth,
rather than being confronted with difficul-
ties when a child is born6–10.The introduction of the routine prenatal
anomaly scan in the Netherlands in 2007
has increased the prenatal detection rate of
CL, CLA, and CLAP substantially, from
5% in the 1980s to over 86% in the past
decade11,12. Prenatal detection rates of
isolated CP are low and remain challeng-
ing. This could be explained by the ab-
sence of obvious facial clues suggesting
the presence of a CP when no other anom-
alies are suspected13.natal diagnosis of isolated cleft, Int J Oral
ons. Published by Elsevier Ltd. All rights reserved.
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Fig. 1. Overview of results: prenatal apparent isolated oral clefts and postnatal additional anomalies.
Cleft type: CL, cleft lip; CLA, cleft lip and alveolus; CLAP, cleft lip, alveolus, and palate; CLA(P), cleft lip, alveolus, and (probably) palate.Invasive prenatal testing is offered
when an OC is diagnosed11. In our labo-
ratory, foetal karyotyping was replaced by
microarray analysis starting in 201114,15.
Despite advanced prenatal diagnostic
methods, not all additional anomalies
may or can be detected before birth. In
17 postnatal studies including 28,953
infants with OC, the prevalence of addi-
tional anomalies varied between 17% and
60%16. The rate of additional anomalies
following a prenatally diagnosed isolated
OC has been reported in only three studiesPlease cite this article in press as: Haj M, et a
Maxillofac Surg (2020), https://doi.org/10.1
Table 1. Prenatal diagnosis and postnatal outco
Sex Birth year
Prenatal
diagnosis
Postnatal
diagnosis Side cle
F 2014 CLAP CLAP L 
M 2014 CLAP CLAP B 
M 2012 CLAP CLA B 
F 2012 CLA CLA L 
F 2011 CLA(P) CLAP L 
M 2010 CLAP CLAP B 
M 2010 CLA(P) CLAP L 
F 2010 CLAP CLAP R 
M 2009 CLA(P) CLAP B 
M 2008 CLAP CLAP L 
M 2003 CLA CLA L 
F 2002 CLA(P) CLAP B 
ASD, atrial septal defect; B, bilateral; BCD, blep
CLA(P), cleft lip, alveolus, and (probably) palat
available.in the recent literature (including 344 foe-
tuses), with this rate varying between 10%
and 30%17–19. These studies did not in-
clude data on chromosomal anomalies
detected by means of microarray analysis.
The aim of this study was to evaluate the
rate and severity of postnatally detected
additional chromosomal aberrations and/
or structural anomalies in infants with a
prenatal diagnosis of isolated oral cleft in
the South-West region of the Netherlands.
The ultimate aim was to enable comprehen-
sive prenatal counselling.l. Undetected anomalies in foetuses with a pre
016/j.ijom.2020.05.005
me of 12 cases with prenatal apparent isolated cl
ft
Prenatal genetic
investigation
Postnatal structural
anomalies
Po
an
x Pre-auricular fistula No
Normal
microarray
ASD type II, mild
peripheral
pulmonary stenosis,
syndactyly
No
Normal
microarray
None Va
x Cleft earlobe No
x None Va
Normal
karyotype
Perimembranous
VSD, ASD type II
No
x Accessory auricle No
Normal
karyotype
Syndactyly No
Normal
karyotype
None Am
co
x None Va
x Syndactyly No
x Congenital ectropion BC
harocheilodontic syndrome; CLA, cleft lip and a
e; F, female; L, left; M, male; R, right; VSD, veMaterials and methods
This was a retrospective cohort study of all
consecutive pregnancies with foetuses di-
agnosed with an isolated OC, live-born
between January 2000 and May 2015 in
the South-West region of the Netherlands.
When an OC was suspected during the
pregnancy, the prospective mother was
referred to Erasmus MC, a tertiary referral
hospital, for a prenatal expert ultrasound
examination, including two-dimensional
and three-dimensional ultrasound. Whennatal diagnosis of isolated cleft, Int J Oral
eft and minor postnatal additional anomalies.
stnatal syndromic
omalies
Postnatal genetic
investigation Death
ne x No
ne x No
n der Woude IRF6 gene
mutation (target
mutation
analysis)
No
ne x No
n der Woude x No
ne No CHD7 gene
mutation (target
mutation
analysis), normal
microarray
No
ne x No
ne x No
niotic band
nstriction left hand
x No
n der Woude x No
ne x No
D CDH1 gene
mutation (target
mutation
analysis)
No
lveolus; CLAP, cleft lip, alveolus, and palate;
ntricular septal defect; ‘x’, not performed/not
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Table 2. Prenatal diagnosis and postnatal outcome of 12 cases with prenatal apparent isolated cleft and major postnatal additional anomalies.
Sex Birth year
Prenatal
diagnosis
Postnatal
diagnosis Side cleft
Prenatal genetic
investigation Postnatal structural anomalies
Postnatal syndromic
anomalies
Postnatal genetic
investigation Death
M 2015 CLAP CLAP L x Subglottic stenosis None x No
M 2014 CLAP CLAP L Normal
microarray
Microcephaly, hepatosplenomegaly,
syndactyly, developmental delay
None x No
M 2014 CLAP CLAP L x Choanal atresia, chorioretinal coloboma,
VSD, laryngomalacia, malformation falx
cerebri, deafness, Ebstein anomaly
CHARGE CHD7 gene mutation
(c.1828dupG) (target
mutation analysis)
Yes, at 4.5 months
(infectious
respiratory failure)
F 2013 CL CLAP L x Radioulnar synostosis None x No
F 2012 CLA CLAP R x Anterior ectopic anus, peripheral
pulmonary stenosis, developmental delay
None arr[hg18]
3p21.31p14.1
(48,012,380-
64,294,973)x3
16.3 Mb 3p21
duplication
No
F 2012 CLAP CLAP L x Unilateral microtia/unilateral external
auditory canal atresia, accessory auricle
None x No
F 2010 CLA(P) CLAP L Normal
karyotype
Patent ductus arteriosus, ASD type II,
severe pulmonary stenosis, epilepsy,
psychomotor retardation
Wolf–Hirschhorn arr[hg18] 4p16
(38,283-8,321,040)
x1
8.3 Mb 4p deletion
Yes, at 31 months
(infectious
respiratory failure)
M 2009 CLA(P) CLAP R x Developmental delay None arr[hg19] 6p21.1
(41318438-
44676420)x1
3.4 Mb 6p21.1
deletion
No
M 2008 CLA(P) CLA B x Ectopic posterior pituitary glands,
persisting cavum septi pellucidi, ASD type
II (clinically insignificant), mild glandular
hypospadias, psychomotor retardation,
congenital dysplasia of the hip
None Derivative
chromosome 3
der(3)del(3)(p25.3)
inv dup(3)
(p22.3p25.3)
arr[hg18] 3p26.3p
25.3(48,603-
8,994,748)
x1,3p25.3p22.3
(9021906-
36061113)x3
8.9 Mb 3p deletion
27Mb 3p duplication
No
F 2008 CLAP CLAP B x Congenital nasal cyst with extension into
the intracranial space, congenital
filamentous adhesion of the upper and
lower eyelids
BCD CTNND1 gene
mutation (target
mutation analysis)
No
M 2004 CLA(P) CLA R Normal
karyotype
Craniofacial microsomia, microtia,
external auditory canal atresia, scoliosis
Goldenhar x No
M 2002 CLA(P) CLAP B Normal
karyotype
Oesophageal atresia, hypertrophic pyloric
stenosis
None x No
ASD, atrial septal defect; B, bilateral; BCD, blepharocheilodontic syndrome; CHARGE, coloboma, heart defects, choanal atresia, growth retardation, genital abnormalities, and ear abnormalities; CL,
cleft lip; CLA, cleft lip and alveolus; CLAP, cleft lip, alveolus, and palate; CLA(P), cleft lip, alveolus, and (probably) palate; F, female; L, left; M, male; R, right; VSD, ventricular septal defect; ‘x’, not
performed/not available.
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Fig. 2. Distribution of additional structural anomalies by organ system.the OC was confirmed, invasive genetic
prenatal testing was offered to identify any
chromosomal aberrations. From 2000 to
2011, conventional karyotyping was avail-
able as a routine diagnostic tool. In mid-
2011, microarray genomic testing was
introduced as common practice. Prospec-
tive parents were counselled by the ‘cleft
team’ on the prognosis and treatment
options prior to 24 weeks of gestation20.
Psychosocial support was available. Fol-
lowing birth, the infant was examined by
a paediatric specialist. The type of cleft
(CL/CLA/CLAP/CP) was confirmed or
revised. The extent of the oral cleft
(unilateral/bilateral) was determined. If
dysmorphic features or an abnormal de-
velopment were suspected, the child was
also examined by a clinical geneticist and
if indicated, a targeted mutation analysis
was performed.
Data were extracted from the hospital’s
electronic health records (Elpado/Astraia).
Based on the ultrasound reports, the type
of cleft was categorized as CL, CLA, CLA
(P), or CLAP. The CLA(P) type was
assigned when following the diagnosis
of CLA, the presence of a cleft palate
was noted as ‘probable but could not be
ascertained on the sonographic images
obtained’. Isolated cleft palates were not
detected prenatally and hence where not
included in this study. The postnatal data
were reviewed by a clinical geneticist,
who categorized any additional anomalies
into minor or major. This was based on the
clinical relevance; abnormalities resulting
in any permanent functional impairment
were considered major. The cases with
chromosomal aberrations were re-evaluat-
ed by a laboratory specialist. Terminated
pregnancies (n = 5) and premature
deliveries (n = 1) were excluded because
phenotypic data were lacking.
Statistical analysis
The statistical analysis was performed
using IBM SPSS Statistics version 21.0
software (IBM Corp., Armonk, NY,
USA). Associations between the prenatal
and postnatal type of OC and postnatal
additional anomalies were tested by logistic
regression analysis. Probabilities less than
0.05 were regarded as being significant.
Results
The data of 176 live-born infants diag-
nosed prenatally with an isolated OC were
included. The postnatal follow-up period
ranged from 1.4 to 16.2 years (median 6
years).Please cite this article in press as: Haj M, et a
Maxillofac Surg (2020), https://doi.org/10.1Prenatal data
During prenatal expert ultrasound exami-
nation, 32 (18.2%) foetuses were diag-
nosed with CL, 35 (19.9%) with CLA,
52 (29.5%) with CLAP, and 57 (32.4%)
with CLA(P) (Fig. 1).
Postnatal data
Postnatal clinical assessment of the OC
confirmed the ultrasound diagnosis in 126/
176 (71.6%) infants, while 50 (28.4%)
diagnoses were revised (Fig. 1): 34
(19.3%) to a more extensive type and 16
(9.1%) to a less extensive type of cleft. A
submucous cleft of the palate was deter-
mined in two infants with a prenatal diag-
nosis of CL and in two with CLA. (Bi)
laterality was revised in 13/176 (7.4%)
infants; seven prenatally unilateral clefts
were diagnosed as bilateral and six prena-
tally bilateral clefts were diagnosed as
unilateral after birth. A unilateral cleft
was seen in 143 (81.3%) infants (15 CL,
39 CLA, 89 CLAP) and a bilateral cleft in
33 (18.8%) infants (1 CL, 6 CLA, 26
CLAP). Ninety-seven of the unilateral
clefts (67.8%) were left-sided and 46
(32.2%) were right-sided.
Postnatal assessment of associated
structural and syndromic anomalies
Additional anomalies were found in 24/
176 (13.6%) infants with a prenatally ap-
parent isolated oral cleft; 12 (6.8%) were
categorized as minor (0 CL, 3 CLA, 9
CLAP) and 12 (6.8%) were categorized
as major (0 CL, 2 CLA, 10 CLAP) (Tables
1 and 2). A higher prevalence of additional
anomalies was noted with increasing se-
verity of the type of cleft in reference to
cleft lip only (CLA: odds ratio (OR) 2.91,
95% confidence interval (CI) 0.29–29.45;
CLA(P): OR 5.81, 95% CI 0.70–48.2;l. Undetected anomalies in foetuses with a pre
016/j.ijom.2020.05.005CLAP: OR 8.32, 95% CI 1.02–67.9). Ad-
ditional anomalies were diagnosed in 16/
143 (11.2%) infants with a unilateral oral
cleft and in 8/33 (24.2%) infants with a
bilateral oral cleft (OR 2.54, 95%
CI 0.98–6.57). No statistical significance
was found.
All infants with additional anomalies
categorized as major had multiple anoma-
lies. Eleven of the 12 infants with anoma-
lies categorized as minor had a single
anomaly. Fig. 2 shows the distribution
of the additional structural anomalies by
organ system. Chromosomal aberrations
and gene mutations associated with known
syndromes were diagnosed in 8/176
(4.5%) infants (one Van der Woude
syndrome, two blepharocheilodontic syn-
drome (BCD), one CHARGE syndrome,
and four pathogenic chromosomal aberra-
tions, of which one was associated with
Wolf–Hirschhorn syndrome). Syndromic
disorders were clinically diagnosed in 3/
176 (1.7%) cases (two Van der Woude and
one Goldenhar syndrome). Two patients
died due to respiratory failure as a result of
a viral pulmonary infection, one at 4.5
months after birth and the other at 31
months. Both had been diagnosed with a
syndromic disorder (CHARGE syndrome
and Wolf–Hirschhorn syndrome).
Chromosomal aberrations and prenatal
cytogenetic diagnosis
Invasive prenatal testing was performed in
87/176 (49.4%) pregnancies; 54/176
(30.7%) by karyotyping and 33/176
(18.7%) by microarray analysis. Eight of
the 87 infants who had undergone amnio-
centesis (9.2%) were diagnosed with ad-
ditional anomalies during the postnatal
period, of which four were major. One
infant with a prenatal normal karyotype
was diagnosed postnatally with a submi-
croscopic 4p deletion associated withnatal diagnosis of isolated cleft, Int J Oral
Undetected anomalies in prenatal isolated cleft 5
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Fig. 3. Three examples of the prenatal and postnatal diagnosis. (A–C) Prenatal diagnosis of cleft lip (CL), confirmed after birth (CL). (D–F)
Prenatal diagnosis of cleft lip (CL), revised to cleft lip and alveolus (CLA) after birth. (G–I) Prenatal diagnosis of cleft lip (CL), revised to cleft lip,
alveolus, and palate (CLAP) after birth. Arrows indicate the cleft lip in the coronal ultrasound image. Arrowheads indicate the cleft lip and
apparent intact alveolus and palate.Wolf–Hirschhorn syndrome identified by
microarray analysis. Prenatal microarray
analysis was not routinely available at the
time of pregnancy.Please cite this article in press as: Haj M, et a
Maxillofac Surg (2020), https://doi.org/10.1Amniocentesis was declined by 89
(50.6%) pregnant women. Postnatal geno-
mic microarray revealed chromosomal
aberrations in the offspring of three ofl. Undetected anomalies in foetuses with a pre
016/j.ijom.2020.05.005these women (3.4%), which were catego-
rized as major: two microscopically visi-
ble (3p21 duplication and a derivative
chromosome 3) and one submicroscopicnatal diagnosis of isolated cleft, Int J Oral
6 Haj et al.
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delay and likely causal for CLAP (3.4
Mb 6p21.1 deletion)21,22. In two of these
cases, additional structural anomalies
were found, and developmental delay
was detected in all three during follow-
up. Furthermore, postnatal targeted muta-
tion analysis identified two gene mutations
in the major group (a CHD7 mutation
associated with CHARGE syndrome and
a CTNND1 mutation associated with BCD
syndrome) and two gene mutations in the
minor group (an IRF6 mutation associated
with Van der Woude syndrome and
a CDH1 mutation associated with BCD
syndrome).
Discussion
Additional congenital structural anoma-
lies and/or constitutive chromosomal
aberrations were found in 13.6% of
patients, half of which were considered
as major. The prenatal diagnosis of the
type of cleft was revised to a more exten-
sive type in 34 (19.3%) infants and to a
less extensive type in 16 (9.1%).
No false-positive prenatal cleft diagno-
ses were noticed, confirming earlier stud-
ies18,23,24. The prenatal diagnosis of the
type of cleft was revised in 28.4% of
infants, which compares well with
the 30% and 35% found in previous
studies12,18. The revisions were most com-
mon in the CL group. The prenatal diag-
nosis of CL was revised in 19/32 (59.4%)
cases to a more extensive type (CLA or
CLAP), and one infant with CLAP was
also revealed to have a radioulnar synos-
tosis. These revisions could be explained
by the challenging detection of mild alve-
olar notches and (submucous) cleft palate,
as reported previously by several authors
and shown in Fig. 325–27. No additional
structural anomalies or chromosomal
aberrations were found in infants with a
postnatal diagnosis of CL.
The type and extent of the OC is related
to the prevalence of additional anoma-
lies2,3,16,24. The present study data confirm
these findings, as the frequency of addi-
tional anomalies increased with involve-
ment of the alveolus and the palate. Only
this study and the study by Depla et al.28
have reported the prenatal diagnoses of
CL, CLA, and CLAP subdivisions,
suggesting differences in the prevalence
of additional anomalies.
Additional anomalies were diagnosed
more frequently in infants with a bilateral
cleft compared to a unilateral cleft, as
also reported by Hagberg et al.29 and
Fleurke-Rozema et al.12.Please cite this article in press as: Haj M, et a
Maxillofac Surg (2020), https://doi.org/10.1In the majority of cases, the prenatal
diagnosis was determined prior to 24
weeks of gestation. The additional struc-
tural anomalies not detected until after
birth were anomalies that may only be-
come evident late in gestation (microceph-
aly and severe pulmonary stenosis)30,31 or
anomalies known to be difficult to diag-
nose due to the variable presentation of
abnormal structures. Examples of the lat-
ter are Ebstein anomaly, ventricular septal
defect, anterior ectopic anus, and oesopha-
geal atresia31–34. Similar anomalies were
not detected before birth in two recent
studies, indicating the limitations of ultra-
sound in pregnancy18,28.
Two of the four patients with an aber-
rant chromosome status carried a large
chromosomal aberration (3p duplication
and derivative chromosome 3); the other
two carried submicroscopic aberrations
(6p21 deletion and 4p deletion). Novel
high-resolution genetic tests such as
microarray-based genomic analysis can
detect all of these chromosomal aberra-
tions, in contrast to conventional karyo-
typing, which has a limited resolution35.
The use of this technique reduces the rate
of undetected chromosomal aberrations
associated with structural and syndromic
malformations36. Contrary to past opi-
nions15,37,38, we believe that invasive ge-
netic testing for all types of OC is
justified in view of the occasional incon-
sistencies in the pre- and postnatal diag-
nosis of the type of cleft in relation to the
prevalence of additional anomalies, the
introduction of microarray analysis, and
the low additional risk of foetal loss
following amniocentesis12,37,38. Microar-
ray testing may reveal chromosomal
aberrations associated with features that
cannot be detected on ultrasound, such as
developmental delay or hypotony, but
which strongly influence the foetal prog-
nosis. Although microarray testing is of-
fered in all pregnancies with anomalies
detected on ultrasound, parents often de-
cline genetic testing, as revealed in the
present study and a previous Dutch
study12. Prior to the microarray era, the
risk of an abnormal karyogram associated
with OC was low39. This might have
influenced counselling concerning inva-
sive procedures. Cultural attitudes in the
Netherlands, in addition to parental fear
of miscarriage could also have played a
role, despite the low risk of pregnancy
loss37,40.
In addition to the chromosomal aberra-
tions detected postnatally by microarray
analysis, gene mutations were identified
using targeted mutation analysis, of which
two were major anomalies (CHARGE andl. Undetected anomalies in foetuses with a pre
016/j.ijom.2020.05.005BCD with intracranial extension). If pre-
natal diagnosis using microarray and
whole exome sequencing (WES) was per-
formed in all cases, the diagnosis of addi-
tional genetic anomalies would have been
possible before birth in an additional 4.5%
(8/176).
The strengths of this study are the large
sample size, the subdivision of cleft types
(CL, CLA, CLAP) and extent (unilateral/
bilateral), and the reporting on the addi-
tional value of microarray analysis. A
main limitation is the retrospective na-
ture. The shorter follow-up period of
infants born in the last 2 years of the
study might have resulted in an underes-
timation of the rate of associated anoma-
lies (especially milder developmental
delay, speech disorders, and intellectual
disability revealed later in life). More-
over, submicroscopic aberrations and
gene mutations were not tested and ex-
cluded in all of the cases during the
follow-up period.
In conclusion, additional anomalies
were seen in almost one in every 7.5
infants diagnosed prenatally with an iso-
lated OC. The introduction of microarray
analysis has increased the diagnosis of
chromosomal aberrations. Involvement
of the alveolus and the palate and a
bilateral cleft appear to be related to a
higher risk of additional anomalies. The
diagnosis of only a CL during prenatal
screening does not rule out the presence
of associated anomalies postnatally, tak-
ing into account the revision rate of the
type of cleft after birth. Possible incon-
sistencies with the final postnatal diagno-
sis of the type of cleft and the rate of
undetected additional anomalies should
be discussed during prenatal parental
counselling.
Patient consent
Not required.
Funding
None.
Ethical approval
Data collection and protection took place
according to the privacy regulations of the
Erasmus MC. Approval was not required
according to the judgement obtained from
the Ethics Review Board of the Erasmus
MC, Rotterdam, the Netherlands (MEC-
2016-576).natal diagnosis of isolated cleft, Int J Oral
Undetected anomalies in prenatal isolated cleft 7
YIJOM-4437; No of Pages 8Competing interests
The authors have no conflicts of interest to
declare.
References
1. Mossey PA, Little J, Munger RG, Dixon MJ,
Shaw WC. Cleft lip and palate. Lancet
2009;374:1773–85.
2. Kraus BS, Kitamura H, Ooe T. Malforma-
tions associated with cleft lip and palate in
human embryos and fetuses. Am J Obstet
Gynecol 1963;86:321–8.
3. Milerad J, Larson O, Hagberg C, Ideberg M.
Associated malformations in infants with
cleft lip and palate: a prospective, popula-
tion-based study. Pediatrics 1997;100(2 Pt
1):180–6.
4. Klassen AF, Tsangaris E, Forrest CR, Wong
KW, Pusic AL, Cano SJ, Syed I, Dua M,
Kainth S, Johnson J, Goodacre T. Quality of
life of children treated for cleft lip and/or
palate: a systematic review. J Plast Reconstr
Aesthet Surg 2012;65:547–57.
5. Sell D, Sweeney T, Harding-Bell A, John
AK. Measuring quality of life in cleft lip and
palate patients: currently available patient-
reported outcomes measures. Plast Reconstr
Surg 2012;130:888e.
6. Davalbhakta A, Hall PN. The impact of
antenatal diagnosis on the effectiveness
and timing of counselling for cleft lip and
palate. Br J Plast Surg 2000;53:298–301.
7. Aspinall CL. Dealing with the prenatal diag-
nosis of clefting: a parent’s perspective. Cleft
Palate Craniofac J 2002;39:183–7.
8. Johansson B, Ringsberg KC. Parents’ experi-
ences of having a child with cleft lip and
palate. J Adv Nurs 2004;47:165–73.
9. Rey-Bellet C, Hohlfeld J. Prenatal diagno-
sis of facial clefts: evaluation of a
specialised counselling. Swiss Med Wkly
2004;134:640–4.
10. Nusbaum R, Grubs RE, Losee JE, Weidman
C, Ford MD, Marazita ML. A qualitative
description of receiving a diagnosis of cleft-
ing in the prenatal or postnatal period. J
Genet Couns 2008;17:336–50.
11. Ensing S, Kleinrouweler CE, Maas SM,
Bilardo CM, Van der Horst CM, Pajkrt E.
Influence of the 20-week anomaly scan on
prenatal diagnosis and management of fetal
facial clefts. Ultrasound Obstet Gynecol
2014;44:154–9.
12. Fleurke-Rozema JH, van de Kamp K, Bak-
ker MK, Pajkrt E, Bilardo CM, Snijders RJ.
Prevalence, diagnosis and outcome of cleft
lip with or without cleft palate in The
Netherlands. Ultrasound Obstet Gynecol
2016;48:458–63.
13. Abramson ZR, Peacock ZS, Cohen HL,
Choudhri AF. Radiology of cleft lip and
palate: imaging for the prenatal period and
throughout life. Radiographics 2015;35:
2053–63.Please cite this article in press as: Haj M, et a
Maxillofac Surg (2020), https://doi.org/10.114. Srebniak M, Boter M, Oudesluijs G, Joosten
M, Govaerts L, Van Opstal D, Galjaard RJ.
Application of SNP array for rapid prenatal
diagnosis: implementation, genetic counsel-
ling and diagnostic flow. Eur J Hum Genet
2011;19:1230–7.
15. Srebniak MI, Boter M, Oudesluijs GO,
Cohen-Overbeek T, Govaerts LC, Dider-
ich KE, Oegema R, Knapen MF, van de
Laar IM, Joosten M, Van Opstal D, Gal-
jaard RJ. Genomic SNP array as a gold
standard for prenatal diagnosis of foetal
ultrasound abnormalities. Mol Cytogenet
2012;5:14.
16. Maarse W, Rozendaal AM, Pajkrt E, Ver-
meij-Keers C, Mink van der Molen AB, van
den Boogaard MJ. A systematic review of
associated structural and chromosomal
defects in oral clefts: when is prenatal ge-
netic analysis indicated? J Med Genet
2012;49:490–8.
17. Chmait R, Pretorius D, Moore T, Hull A,
James G, Nelson T, Jones M. Prenatal detec-
tion of associated anomalies in fetuses diag-
nosed with cleft lip with or without cleft
palate in utero. Ultrasound Obstet Gynecol
2006;27:173–6.
18. Burnell L, Verchere C, Pugash D, Loock C,
Robertson S, Lehman A. Additional post-
natal diagnoses following antenatal diagno-
sis of isolated cleft lip +/- palate. Arch Dis
Child Fetal Neonatal Ed 2014;99:F286–290.
19. Depla AL, Breugem CC, van der Horst CM,
de Heus R, van den Boogaard MH, Maas
SM, Pajkrt E, Bekker MN. Polyhydramnios
in isolated oral cleft pregnancies: incidence
and outcome in a retrospective study. Prenat
Diagn 2017;37:162–7.
20. Exalto N, Cohen-Overbeek TE, van Adri-
chem LN, Oudesluijs GG, Hoogeboom AJ,
Wildschut HI. Prenataal vastgestelde orofa-
ciale schisis [Prenatally detected orofacial
cleft]. Ned Tijdschr Geneeskd 2009;153.
B316. Dutch.
21. Cobourne MT. The complex genetics of cleft
lip and palate. Eur J Orthod 2004;26:7–16.
22. Hill C, Jacobs B, Kennedy L, Rohde S, Zhou
B, Baldwin S, Goudy S. Cranial neural crest
deletion of VEGFa causes cleft palate with
aberrant vascular and bone development.
Cell Tissue Res 2015;361:711–22.
23. Matthews MS, Cohen M, Viglione M,
Brown AS. Prenatal counseling for cleft
lip and palate. Plast Reconstr Surg
1998;101:1–5.
24. Berge´ SJ, Plath H, Van de Vondel PT, Appel
T, Niederhagen B, Von Lindern JJ, Reich
RH, Hansmann M. Fetal cleft lip and palate:
sonographic diagnosis, chromosomal abnor-
malities, associated anomalies and postnatal
outcome in 70 fetuses. Ultrasound Obstet
Gynecol 2001;18:422–31.
25. Maarse W, Berge´ SJ, Pistorius L, van Bar-
neveld T, Kon M, Breugem C, Mink van der
Molen AB. Diagnostic accuracy of transab-
dominal ultrasound in detecting prenatal
cleft lip and palate: a systematic review.l. Undetected anomalies in foetuses with a pre
016/j.ijom.2020.05.005Ultrasound Obstet Gynecol 2010;35:495–
502.
26. Maarse W, Pistorius LR, Van Eeten WK,
Breugem CC, Kon M, Van den Boogaard
MJ, Mink van Der Molen AB. Prenatal
ultrasound screening for orofacial clefts.
Ultrasound Obstet Gynecol 2011;38:434–9.
27. Loozen CS, Maarse W, Manten GT, Pistorius
L, Breugem CC. The accuracy of prenatal
ultrasound in determining the type of orofa-
cial cleft. Prenat Diagn 2015;35:652–5.
28. Depla AL, Breugem CC, van der Horst CM,
de Heus R, van den Boogaard MH, Maas
SM, Pajkrt E, Bekker MN. Polyhydramnios
in isolated oral cleft pregnancies: incidence
and outcome in a retrospective study. Prenat
Diagn 2017;37:162–7.
29. Hagberg C, Larson O, Milerad J. Incidence
of cleft lip and palate and risks of additional
malformations. Cleft Palate Craniofac J
1998;35:40–5.
30. Leibovitz Z, Daniel-Spiegel E, Malinger
G, Haratz K, Tamarkin M, Gindes L,
Schreiber L, Ben-Sira L, Lev D, Shapiro
I, Bakry H, Weizman B, Zreik A, Egenburg
S, Arad A, Tepper R, Kidron D, Lerman-
Sagie T. Prediction of microcephaly at
birth using three reference ranges for fetal
head circumference: can we improve pre-
natal diagnosis? Ultrasound Obstet Gyne-
col 2016;47:586–92.
31. van Velzen CL, Clur SA, Rijlaarsdam ME,
Bax CJ, Pajkrt E, Heymans MW, Bekker
MN, Hruda J, de Groot CJ, Blom NA, Haak
MC. Prenatal detection of congenital heart
disease—results of a national screening pro-
gramme. BJOG 2016;123:400–7.
32. de Jong EM, de Haan MA, Gischler SJ, Hop
W, Cohen-Overbeek TE, Bax NM, de Klein
A, Tibboel D, Grijseels EW. Pre- and post-
natal diagnosis and outcome of fetuses and
neonates with esophageal atresia and tra-
cheoesophageal fistula. Prenat Diagn
2010;30:274–9.
33. Dearani JA, Mora BN, Nelson TJ, Haile DT,
O’Leary PW. Ebstein anomaly review:
what’s now, what’s next? Expert Rev Car-
diovasc Ther 2015;13:1101–9.
34. Lee MY, Won HS, Shim JY, Lee PR, Kim
A, Lee BS, Kim EA, Cho HJ. Sonographic
determination of type in a fetal imperfo-
rate anus. J Ultrasound Med 2016;35:
1285–91.
35. de Wit MC, Srebniak MI, Govaerts LC,
Van Opstal D, Galjaard RJ, Go AT. Addi-
tional value of prenatal genomic array
testing in fetuses with isolated structural
ultrasound abnormalities and a normal
karyotype: a systematic review of the
literature. Ultrasound Obstet Gynecol
2014;43:139–46.
36. Srebniak MI, Van Opstal D, Joosten M,
Diderich KE, de Vries FA, Riedijk S, Kna-
pen MF, Go AT, Govaerts LC, Galjaard RJ.
Whole-genome array as a first-line cyto-
genetic test in prenatal diagnosis. Ultra-
sound Obstet Gynecol 2015;45:363–72.natal diagnosis of isolated cleft, Int J Oral
8 Haj et al.
YIJOM-4437; No of Pages 837. Akolekar R, Beta J, Picciarelli G, Ogilvie C,
D’Antonio F. Procedure-related risk of mis-
carriage following amniocentesis and chori-
onic villus sampling: a systematic review
and meta-analysis. Ultrasound Obstet Gyne-
col 2015;45:16–26.
38. Wulff CB, Gerds TA, Rode L, Ekelund CK,
Petersen OB, Tabor A. Danish Fetal Medi-
cine Study Group. Risk of fetal loss associ-
ated with invasive testing following
combined first-trimester screening for Down
syndrome: a national cohort of 147,987 sin-Please cite this article in press as: Haj M, et a
Maxillofac Surg (2020), https://doi.org/10.1gleton pregnancies. Ultrasound Obstet
Gynecol 2016;47:38–44.
39. Gillham JC, Anand S, Bullen PJ. Antenatal
detection of cleft lip with or without cleft
palate: incidence of associated chromosomal
and structural anomalies. Ultrasound Obstet
Gynecol 2009;34:410–5.
40. van den Heuvel A, Marteau TM. Cultural
variation in values attached to informed
choice in the context of prenatal diagnosis.
Semin Fetal Neonatal Med 2008;13:99–
102.l. Undetected anomalies in foetuses with a pre
016/j.ijom.2020.05.005Address:
Mona Haj
Department of Maxillofacial Surgery
Erasmus MC – Sophia Children’s Hospital
University Medical Centre Rotterdam
Dr. Molenwaterplein 40
3015 GD Rotterdam
The Netherlands
Tel: +31 614187875
E-mail: m.haj@erasmusmc.nlnatal diagnosis of isolated cleft, Int J Oral
